Tresiba FlexTouch 200 (Insulin Degludec)
Get your FREE e-consultation.
You'll have the option to make 4-interest-free payments by credit card once your order is confirmed using Sezzle.
This is a refrigerated product. A default $29.99 Express shipping fee is applied. It will be shipped out in a insulated styrofoam container with gel and ice packs inside. Parcels are shipped via Canada Post Express.
Tresiba (Insulin Degludec)
Tresiba (insulin degludec) is a long-acting insulin medication used to help control high blood sugar levels in adults and children with diabetes mellitus. Developed to provide a consistent and prolonged release of insulin, Tresiba offers a stable and effective approach to managing diabetes. With its longer duration of action, Tresiba can help minimize the risk of high or low blood sugar levels, providing better blood sugar control and flexibility in daily routines.
Why Choose Tresiba?
- Long-acting insulin: Tresiba provides a steady release of insulin over 42 hours, ensuring continuous blood sugar control for those with diabetes.
- Flexible dosing: With its long duration of action, Tresiba allows for more flexibility in dosing times, making it easier to fit into your daily routine.
- Lower risk of hypoglycemia: The consistent release of insulin provided by Tresiba helps reduce the risk of low blood sugar levels (hypoglycemia) compared to other insulin medications.
- Pediatric use: Tresiba® is approved for use in children aged one year and older, providing a reliable insulin option for young patients with diabetes.
How to use Tresiba?
Tresiba is administered as a subcutaneous injection, typically once daily. It is important to follow your healthcare provider’s instructions regarding the proper dosage and administration technique. Be sure to rotate injection sites to minimize the risk of lipodystrophy (changes in fat tissue at the injection site). Always check the insulin label to ensure you are using the correct type of insulin before each injection.
Important Safety Information Tresiba
Before starting Tresiba (insulin degludec) for the management of diabetes, it is crucial to be aware of the precautions and potential interactions associated with its use. Discuss your medical history with your healthcare provider, and inform them of any medications, supplements, or herbal products you are currently taking.
Fact Table
Generic Name | Insulin Degludec |
Brand Name | Tresiba |
Drug Class | Long-acting Insulin |
FDA Approval | September 2015 |
Indication | Management of blood sugar levels in people with diabetes |
Administration | Subcutaneous injection |
Injection Sites | Thigh, upper arm, or abdomen |
Dosing | Individualized, based on the patient’s needs and blood sugar levels |
Onset of Action | 1-2 hours |
Duration of Action | Up to 42 hours |
Storage | Unopened vials and pens: Refrigerate (36°F to 46°F); Opened pens: Room temperature (up to 56 days) |
Hypoglycemia Risk | Possible; monitor blood sugar levels regularly and be aware of symptoms |
Interactions | Some medications, such as oral diabetes drugs, beta-blockers, diuretics |
Common Side Effects
As with any medication, Tresiba® may cause side effects. The most common side effects include
- Hypoglycemia (low blood sugar)
- Allergic reactions
- Weight gain
- Swelling
- Rash
- Difficulty breathing
How Can You Buy Tresiba (Insulin Degludec)?
You can order Tresiba using these methods on our website:
- Order Online
- Order by Phone
- Order by Fax
- Order your refills
Visit our How to order page.